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In the blind subterranean mole rat Spalax ehrenbergi
superspecies complete ablation of the visual image-
forming capability has been accompanied by an expan-
sion of the bilateral projection from the retina to the
suprachiasmatic nucleus. We have cloned the open read-
ing frame of a visual pigment from Spalax that shows
>90% homology with mammalian rod pigments. Baculo-
virus expression yields a membrane protein with all
functional characteristics of a rod visual pigment (lmax
5 497 6 2 nm; pKa of meta I/meta II equilibrium 5 6.5;
rapid activation of transducin in the light). We not only
provide evidence that this Spalax rod pigment is fully
functional in vitro but also show that all requirements
for a functional pigment are present in vivo. The physi-
ological consequences of this unexpected finding are
discussed. One attractive option is that during adapta-
tion to a subterranean lifestyle, the visual system of this
mammal has undergone mosaic reorganization, and the
visual pigments have adapted to a function in circadian
photoreception.
Spalax ehrenbergi represents an extreme model of a subter-
ranean rodent, spending all its life in underground darkness
with only a few occasional exits aboveground. Consequently, it
displays a mosaic of reductional (regressions) and expansional
(progressions) adaptation at all organizational levels. This mo-
saic evolution is most prominent in ocular and brain structures
(1). Thirty million years of adaptation to a subterranean envi-
ronment and lifestyle has resulted in a natural degeneration of
the visual system of mole rats (family Spalacidae). In this
process, the eye of Spalax has been reduced to a very small size
(#1 mm) and regressed to a subcutaneous location, embedded
in a hypertrophied Harderian gland. Whereas the morpholog-
ical development of the retina is normal, with a characteristic
stratified organization, the anterior eye segments start to de-
generate early in development (2). Neuronal components of the
visual pathways are regressed or absent, and anatomically no
visual cortex can be identified (3). Likewise, electrophysiologi-
cal measurements did not obtain any indication for functional
visual pathways (1, 4). In contrast, bilateral projections from
the retina to the suprachiasmatic nucleus have been expanded
(5), and Spalax has preserved the ability to entrain its biolog-
ical clock to environmental light cues (6). Removal of the eyes
abolishes circadian photoentrainment (7), demonstrating that
the circadian photoreceptor system is located in the eye. De-
spite the degenerate nature of its visual system, Spalax has
retained a well organized retina that expresses both a rod-like
and a cone-like visual pigment. Recently a green cone-like
visual pigment was cloned from Spalax and spectrally identi-
fied via functional expression (6), but to date only immunohis-
tochemical evidence for the presence of a rod-like pigment has
been presented (2, 8). Here we present an extensive character-
ization of this pigment. Its sequence is characteristic for a rod
visual pigment and has retained very high homology with rod
pigments of sighted mammals. Through functional expression
with recombinant baculovirus we provide ample biochemical
evidence that this pigment behaves like a fully functional rod
pigment. Considering the absence of any visual ability, a pos-
sible novel function for the visual pigments of Spalax is
discussed.
EXPERIMENTAL PROCEDURES
Cloning of the Spalax Rod Pigment—Total RNA was isolated from
Spalax eyes using Trizol reagent (Life Technologies, Inc.), and approx-
imately 2 mg of RNA was used to synthesize cDNA by means of reverse
transcription (Superscript II reverse transcriptase; Life Technologies,
Inc.). polymerase chain reaction amplification was performed using Pfu
proofreading polymerase (Stratagene) in combination with degenerate
nested and/or specific rod opsin primers. The degenerate and specific
primers, respectively, were as follows: degenerate forward, 59-GTG-RT-
S-TGY-AAR-CCB-39 (exon II) and 59-AAT-GTC-GAC-CAY-GCY-ATC-
ATG-GTY-39 (exon II, nested); degenerate reverse, 59-RTA-RAT-SAY-
VGG-RTT-39 (exon IV) and 59-AAT-GTC-GAC-GCC-CTG-RTG-GGT-G-
AA-39 (exon IV, nested); specific forward, 59-ATG-AAC-GGC-ACA-GA-
G-GG-39 (exon I); and specific reverse, 59-CAT-CAC-CCA-GGA-GGT-T-
CT-TGC-39 (exon V). 59 and 39 rapid amplification of cDNA ends were
performed using a 59/39 rapid amplification of cDNA ends kit (Roche
Molecular Biochemicals) in combination with an opsin-specific reverse
primer in exon I (59-AAG-TTG-AGC-AGG-ATG-TAG-39) and the above-
mentioned forward-nested degenerate rod opsin primer in exon II,
respectively. The obtained full-length open reading frame was checked
on the genomic level by means of the expanded long template
polymerase chain reaction system (Roche Molecular Biochemicals)
using 500 ng of genomic DNA and a rod opsin-specific primer (59-TCT-
ACG-TGC-CCT-TCT-CCA-ACG-39) in exon I in combination with the
above-mentioned specific rod opsin reverse primer in exon V. The ob-
tained partial sequence was identical to the corresponding cDNA se-
quence. A forward primer with a BamHI site (59-GGC-GGG-ATC-CAT-
GAA-CGG-CA-39) and a reverse primer containing a NarI site (59-TTA-
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GGC-CGG-CGC-CAC-CTG-G-39) were used in combination with the
Pfu proofreading polymerase to clone the Spalax rod opsin cDNA in a
baculovirus transfer vector modified from pFastbacdual (Life Technol-
ogies, Inc.). This modified transfer vector contains a BamHI site and a
NarI site in frame with the remaining 39 part of the Spalax rod opsin
sequence extended with an oligonucleotide coding for 6 histidines
(His-tag).
Functional Expression—The transfer vector containing the His-
tagged Spalax rod opsin cDNA was used to generate recombinant
baculovirus in a Spodoptera frugiperda-derived cell line (IPLB-Sf9)
using the Bac-to-bac system (Life Technologies, Inc.) according to man-
ufacturer’s instructions. Generation and amplification of the recombi-
nant baculovirus was performed in a monolayer of Sf9 cells, cultured in
TNM-FH medium supplemented with 10% (v/v) fetal calf serum, 50
units/ml penicillin, and 50 mg/ml streptomycin (Life Technologies, Inc.).
For expression of recombinant protein (9) Sf9 cells were adapted to
suspension culture in 250-ml spinner flasks (Bellco) in serum-free In-
sectXpress medium (Biowhittaker), infected in mid log phase with a
multiplicity of infection of 0.1, and finally harvested 5 days
post-infection.
Regeneration with 11-cis Retinal, Purification, and Reconstitution of
Recombinant Pigment—At 5 days post-infection the infected Sf9 cells
were harvested by centrifugation (10 min; 1000 3 g at 26 °C) and
resuspended at a concentration of 108 cells/ml in buffer A (6 mM Pipes,1
10 mM EDTA, pH 6.5), supplemented with 5 mM b-mercaptoethanol and
2 mg/ml leupeptin. The suspension was homogenized in a Potter-
Elvehjem homogenizer and centrifuged (10 min; 40,000 3 g at 4 °C).
The pellet containing the cellular membranes was resuspended at a
concentration equivalent to 108 cells/ml in buffer B (20 mM Pipes, 130
mM NaCl, 10 mM KCl, 3 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 2 mg/ml
leupeptin, pH 6.5). All subsequent manipulations are performed under
deep red light (Schott R630 longpass filter). Regeneration of the recom-
binant Spalax opsin into rhodopsin was performed under argon by
addition of a concentrated 11-cis retinal solution in dimethylformamide
to the membrane suspension in an amount of 10 nmol/108 cells. The
mixture was incubated under continuous rotation for 30 min at room
temperature followed by 1 h at 4 °C. To extract the rhodopsin from the
membranes N-dodecyl-b-D-maltoside was added to a final concentration
of 1% (w/v), and the resulting mixture was incubated for 1 h under
argon with continuous rotation at 4 °C. After centrifugation (30 min;
120,000 3 g at 4 °C) the supernatant was diluted 1:1 with buffer C (20
mM bis-Tris propane, 0.5 M NaCl, 20% glycerol (v/v), 5 mM b-mercapto-
ethanol, 1 mM histidine, 2 mg/ml leupeptin, 40 mM N-nonyl-b-D-gluco-
side, pH 7.0).
The solubilized pigment was purified by immobilized metal affinity
chromatography over Ni21 nitrilotriacetic acid resin (Qiagen) in a slight
modification from previously described procedures (9, 10). Prior to pu-
rification the pigment concentration in the extract was determined by
UV-visible difference spectroscopy (10), and the pH value was raised to
7.0–7.2 by addition of several aliquots of 200 mM unbuffered bis-Tris
propane solution. The Ni21 nitrilotriacetic acid resin (25–30 ml of resin/
nmol of pigment) was washed with 10 volumes of distilled water and
buffer C, respectively. The protein extract was then applied to the
column and washed with approximately 10 column volumes of buffer C
followed by approximately 10 column volumes of a linear gradient
prepared from buffers C and D (buffer D, buffer C with the histidine
concentration raised to 5 mM and containing 20 mM N-nonyl-b-D-gluco-
side). Elution was accomplished using buffer E (20 mM bis-Tris propane,
140 mM NaCl, 20% glycerol (v/v), 20 mM N-nonyl-b-D-glucoside, 5 mM
b-mercaptoethanol, 50 mM histidine, 2 mg/ml leupeptin, pH 6.5). Frac-
tions were screened by UV-visible spectroscopy, and those containing
over 0.5 nmol of rhodopsin/ml were combined.
To reconstitute the purified pigment into a lipid membrane (proteo-
liposomes) a 100-fold molar excess of bovine retina lipids in buffer F (20
mM Pipes, 130 mM NaCl, 15 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 0.1 mM
EDTA, 2 mg/ml leupeptin, pH 6.5) supplemented with 20 mM N-nonyl-
b-D-glucoside and 1 mM dithioerythritol was added to the combined
rhodopsin fractions. Preparation of bovine retina lipids and removal of
the detergent through addition of b-cyclodextrin to a final concentration
of 20 mM were performed as described before (11). Purification of the
proteoliposomes containing the reconstituted pigment was accom-
plished on a discontinuous sucrose gradient (10, 20, and 45% sucrose
(w/w)) in buffer F (11). After 16 h of centrifugation at 120,000 3 g and
4 °C the pigment containing proteoliposomes were isolated from the
20–45% interface and diluted with 4 volumes of buffer B. The mem-
branes were then pelleted (200,000 3 g, 30 min at 4 °C) and stored at
280 °C in light-tight containers.
For spectral analysis of the pigment a PerkinElmer Life Sciences
Lambda 15 spectrophotometer was used with the cuvette house ther-
mostrated at 10 °C. Membrane samples were used for analysis of the
slow photocascade transitions (rhodopsin 3 meta II 3 meta III) as
described before (12). Absorbance spectra were measured after solubi-
lization in buffer B containing 20 mM N-dodecyl-b-D-maltoside. The
samples were supplemented with hydroxylamine to a final concentra-
tion of 20 mM and were measured before and after illumination with a
75-watt light bulb. Difference spectra were obtained by subtraction of
the “dark” from the “illuminated” spectrum.
Transducin Activation Assay—Activation of the bovine G-protein
transducin (Gt) by the Spalax rod pigment was measured by the intrin-
sic fluorescence enhancement of the G-protein a subunit upon GTP
binding (13). Native bovine rhodopsin or reconstituted pigment samples
(;20 ml) of recombinant His-tagged Spalax or bovine rhodopsin (final
concentration of 5 nM) were added under illumination to a stirred
cuvette containing, in a final volume of 2 ml, 100 nM bovine transducin,
100 mM NaCl, 2 mM MgCl2, 1 mM dithioerythritol, 0.01% (w/v) N-dode-
cyl-b-D-maltoside, 20 mM Hepes, pH 7.4. The sample fluorescence was
measured using a Shimadzu RF—5301–PC spectrofluorometer with
excitation at 295 nm and emission at 337 nm, and after a stabilization
period of 200 s, guanosine 59-O-(3-thiotriphosphate) was added to a
final concentration of 2.5 mM. The subsequent increase in relative flu-
orescence intensity represents pigment-triggered activation of Gta. The
same assay in the absence of pigment was used as a negative control.
Constitutive activity of the apoprotein opsin was assayed in the same
way, except that the pigment samples were illuminated in the presence
of 50 mM hydroxylamine to convert photointermediates and retinal into
opsin and retinaloxime before they were added to the transducin
solution.
To measure any dark activity of the pigment, the fluorescence en-
hancement assay was used, as well, but was modified as follows: about
25 ml of a solution containing dark pigment, transducin, and the other
compounds in the same composition as given above was prepared under
deep red light. Guanosine 59-O-(3-thiotriphosphate) was then added to
a final concentration of 2.5 mM, and at subsequent 10-min intervals 2-ml
samples were withdrawn. After 80–90 min the remaining solution was
illuminated, and subsequently 2-ml samples were taken every minute
to measure the light activation level. Every 2-ml sample was provided
immediately with 50 ml of 1 M hydroxylamine (pH 7.5) and 50 ml of 25
mM N-dodecyl-b-D-maltoside to quench any ongoing and latent G-pro-
tein activation activity. Control experiments showed that under these
conditions G-protein activation by light-activated rhodopsin is
quenched below 1% its normal rate. The samples were illuminated, and
their fluorescence level was measured as described above for the con-
tinuous assay. This level was stable for at least 4 min.
Microspectrophotometry—Spalax eyes were isolated from dark-
adapted animals and the retina was excised and mounted between
coverslips in the microscope, and potential outer segment material was
identified under infrared illumination. The spectral transmission of the
photoreceptor outer segments was scanned using a 2-mm diameter
beam of monochromatic light over the wavelength range of 350 to 750
nm (14). This resulted in the dark spectrum. Following a 3-min expo-
sure to white light this procedure was repeated to establish whether the
pigment is photosensitive. The dark spectrum was fitted with standard
Dartnall templates for a vitamin A1-based visual pigment (14).
Immunohistological Analysis—Polyclonal antibodies CERN886
against rhodopsin and CERN9412 against Gta were described previ-
ously (15). Monoclonal antibodies against rhodopsin (1D4) or against
Gta were obtained from R. S. Molday (16) and A. M. Spiegel (17),
respectively.
Spalax occular tissue was fixed in 4% paraformaldehyde/PBS and
mouse ocular tissue in Bouin fixative (3 volumes saturated picrine acid,
1 volume 37% formaldehyde, and 0.2 volume of acetic acid). Paraffin-
embedded 4-mm sections were used for antibody incubations and hema-
toxylin/eosin staining. Spalax and mouse ocular tissue were incubated
according to standard procedures with 1D4 or anti-Gta (dilutions 1:50
and 1:100 in PBS/10% fetal calf serum, respectively) and with
CERN886 or CERN9412 (dilutions 1:100 and 1:500 in PBS/10% fetal
calf serum, respectively).
Bound antibody was visualized by incubation with a fluorescent
second antibody (fluorescein isothiocyanate-rabit anti-mouse (DAKO)
for 1D4 and anti-Gta, fluorescein isothiocyanate-goat anti-rabbit
(DAKO) for CERN886 and CERN9412; dilutions 1:50 in PBS/10% fetal
1 The abbreviations used are: Pipes, 1,4-piperazinediethanesulfonic
acid; Gt, G-protein transducin; PBS, phosphate-buffered saline; bis-
Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.























calf serum). Coverslips were mounted using a ProLong anti-fade kit
(Molecular Probes) according to the manufacturer’s instructions. Fluo-
rescence microscopy was performed on a Zeiss Axioskop microscope.
RESULTS AND DISCUSSION
Structural and Functional Characterization of the Spalax
Rod Visual Pigment in Vitro—To clone the rod pigment from
Spalax retina we conducted RT polymerase chain reaction and
59 and 39 rapid amplification of cDNA ends on total ocular RNA
using degenerate and rhodopsin-specific primers. The amino
acid sequence deduced from the full-length cDNA displays a
very high similarity with other mammalian rhodopsins (91–
95%), and all elements essential for a functional visual pigment
are conserved (Fig. 1).
To establish whether the isolated cDNA encodes for a func-
tional rod pigment we extended the cDNA C-terminally with a
63 His-tag to allow easy purification and expressed it using the
baculovirus system. After regeneration with the chromophore,
11-cis retinal, purification was accomplished using immobi-
lized metal affinity chromatography (10). This yields a purified
protein that has an apparent molecular mass of 40 kDa (Fig. 2)
and an absorbance spectrum with a peak spectral activity of
497 6 2 nm (Fig. 3). As expected, the spectral properties are
very similar to those of rod pigments in sighted animals, be-
cause all known spectral tuning sites (18) have been conserved
in Spalax. However, immunoblots of Spalax eye extracts sug-
gest a higher molecular mass of ;43 kDa (Fig. 2). Because the
protein component of the Spalax and bovine rod pigments are
very similar (39 kDa), and the recombinant pigments display
the same molecular mass (Fig. 2), most likely the native Spalax
pigment contains larger oligosaccharide moieties on its two
N-glycosylation sites, which will reduce its electrophoretic mo-
bility. The very small Spalax eye only contains minute
amounts of rhodopsin (;5 pmol (8)), which so far has prohibited
isolation and structural characterization of the native protein.
To study the pigment’s photocascade and receptor activity in
a native-like environment, we reconstituted the pigment into
proteoliposomes of bovine retina lipids (11). The reconstituted
Spalax rhodopsin displays typical rod pigment photochemical
behavior (pKa of meta I/meta II equilibrium of 6.5; half-time of
meta II decay of 15 6 3 min at 10 °C). Spalax is very similar to
the human rod pigment in this respect (19). Note that the decay
of meta II is typically much faster in cone pigments (t1⁄2 , 3 min
(20)). The structural transitions accompanying receptor activa-
tion were probed by fourier transform-infared difference spec-
troscopy and were found to be almost identical to recombinant
His-tagged bovine rhodopsin (not shown). This already implies
that the Spalax rod pigment should be able to activate the rod
G-protein transducin. Indeed, in an in vitro assay (13) it
achieves a light-induced activation rate very similar to that of
FIG. 2. Western blot analysis of rhodopsin preparations using
CERN886 anti-rod polyclonal antibody (dilution 1:1000). Left
panel, Spalax eye extract (lane 1) and mouse eye extract (lane 2). Right
panel, Sf9 cells expressing His-tagged Spalax rhodopsin (lane 3); N-do-
decyl-b-D-maltoside extract of Sf9 cells (lane 4); purified and reconsti-
tuted His-tagged Spalax rhodopsin (lane 5); purified and reconstituted
His-tagged bovine rhodopsin (lane 6). Note the apparent higher molec-
ular mass of native Spalax rhodopsin (lane 1, 43 kDa) relative to mouse
(lane 2, 40 kDa).
FIG. 1. Multiple sequence align-
ment of the amino acid sequence of
Spalax, rat, and mouse rhodopsin.
The nucleotide sequence of Spalax rho-
dopsin cDNA contains an open reading
frame that codes for 348 amino acid pro-
teins and shares approximately 95% sim-
ilarity with other rodent rhodopsins like
rat and mouse. The amino acid substitu-
tions in Spalax compared with rat (16 in
total) and mouse (19 in total) rhodopsin
are boxed. Note (arrows) the presence in
Spalax of the over all vertebrate visual
pigments fully conserved residues
Lys-296 (11-cis retinal binding), Glu-113
(counterion), and Cys-110 and Cys-187
(disulfide bridge). The fifth arrow indi-
cates the Glu residue at position 122,
highly characteristic for rod visual pig-
ments. The Spalax sequence is available
under GenBand™ acession number
AF309568.























native and of recombinant bovine rhodopsin (see Fig. 4 and
Table I). The dark activity of the Spalax pigment is very low,
and the constitutive activity of the apoprotein opsin is quite
low, as well (Table I), very similar to the properties reported for
bovine rhodopsin (Table I) (13). We therefore conclude that in
vitro the Spalax rod photopigment behaves as a fully functional
visual pigment.
Functional Characterization of the Spalax Rod Pigment in
Vivo—Do we have evidence for a functional pigment in vivo?
Both 11-cis retinal (8) and a functional interphotoreceptor ret-
inoid binding protein (21) have been identified in Spalax ret-
ina, suggesting a functional visual cycle. Therefore, we at-
tempted to identify a photopigment in vivo by means of
microspectrophotometry. Despite a much lower degree of orga-
nization of Spalax photoreceptor outer segments we managed
to determine the spectral absorbance of several outer segments
in retinas isolated from dark-adapted animals (Fig. 5). The
corresponding pigment is photosensitive, and its absorbance
curve obeys the Dartnall standard template for a vitamin A1-
based visual pigment (14). The dashed curve (Fig. 5) represents
a template with a peak absorbance at 497 nm, as determined
for the recombinant pigment. This template fit is not optimal,
which could be because of the noise level in the spectral data or
might indicate that in vivo the absorbance of the pigment is
slightly shifted to the red. Such small discrepancies between
spectral data of native and recombinant pigments have been
observed before (18). Nevertheless, the close agreement of the
in vivo spectrum with our in vitro data strongly argues that the
Spalax retina contains a photoactive rod pigment.
A functional visual pigment requires co-localization with the
rod Gt. To address that question, we performed immunohisto-
chemical analysis of Spalax retina with anti-rhodopsin and
anti-Gta antibodies. We observed abundant expression of rod
pigment in Spalax photoreceptor outer segments and clear
staining of inner segments and the outer nuclear layer (Fig.
6C). This is similar to the picture obtained for mice (Fig. 6D).
Gta expression was observed in Spalax but only in the outer
segment layer (Fig. 6E) in contrast to mouse where Gta is
detected throughout the entire photoreceptor cell (Fig. 6F).
This could be because of a lower avidity of the antiserum for
Spalax Gta. However, the same pattern was observed with
different dilutions of the antiserum and with the monoclonal
anti-Gta antibody raised against a highly conserved sequence
of Gta (17). Rather this suggests that in Spalax the expression
level of Gta relative to rhodopsin is lower as compared with
mouse. This might be related to the subterranean environment
of the mole rat. For instance, to guarantee maximal photon
capture under the very low light intensities experienced by
Spalax, the high expression level of visual pigment, typical for
sighted animals, should be maintained. Nevertheless, the level
of activated pigment will be very low, and signal transduction
should be able to operate with much lower Gt levels than in
sighted animals. Considering our in vitro data (spectral prop-
erties and full activation of Gt) and the in vivo evidence for the
same photosensitive pigment co-localized with Gta, we con-
clude that the Spalax rod visual pigment is functional in vivo
and uses the same photocascade as sighted animals.
A Functional Photopigment in a Blind Mammal: Rudiment
or Mosaic Reorganization?—Although visual pigments have
been identified before in blind animals like the cave fish Asty-
anax (22) and crayfish (23), we here report the first extensive
functional characterization of a visual pigment in a blind mam-
mal. In other blind animals loss of sight seems to be accompa-
nied by deficiencies in gene expression or pigment functionality
(22–24). In contrast, the rod visual pigment of the blind mole
rat we have cloned is highly conserved and exhibits full
functionality.
A major question then is why a blind mammal, despite mo-
FIG. 4. Light-dependent activation of bovine Gt by the Spalax
rod pigment. Intrinsic fluorescence enhancement of the G-protein a
subunit upon GTP binding was used to monitor activation by either
native bovine rhodopsin (trace 3) or recombinant His-tagged Spalax
(trace 1) or bovine (trace 2) rhodopsin. As a negative control the activa-
tion rate in the absence of pigment was measured (trace 4). All pigments
were present at the same concentration (5 nM), and the reaction was
initiated by the addition of guanosine 59-O-(3-thiotriphosphate)
(GTPgS) to 2.5 mM (arrow).
TABLE I
Transducin (Gt) activation by Spalax rhodopsin relative to
bovine rhodopsin
The light-dependent initial activation rate measured for native bo-
vine rhodopsin was set at 1 (see Fig. 4). n 5 3–5. N.A., not applicable.
Preparation Condition Initial rate
Recombinant his-tagged
bovine rhodopsin
dark 0.01 6 0.01
light 0.97 6 0.05
Recombinant his-tagged
Spalax rhodopsin
dark 0.01 6 0.01
light 0.95 6 0.06
Recombinant his-tagged
Spalax opsin
N.A. 0.05 6 0.03
FIG. 3. Spectral properties of purified reconstituted Spalax
rhodopsin. The photopigment displays a peak spectral activity at
497 6 2 nm. The A280/A500 ratio is approximately 3.5. This is higher
then for purified rod pigments (1.7–2.0) because of the excess of lipid
that contributes to the UV absorbance. The inset shows the difference
spectrum, obtained by subtracting the dark spectrum from the spec-
trum after illumination. The spectra were measured in the presence of
20 mM hydroxylamine to convert the liberated all-trans retinal into
all-trans retinoxime with an absorbance maximum at 365 nm.























saic reorganization of visual structures to an auditory function
(1, 3, 5), has retained a fully functional visual pigment? The
subcutaneous location of the eye and the complete degenera-
tion of the lens (2) already abolish any capacity of the retina to
transfer image information. In fact, all available evidence,
based upon anatomical, electrophysiological, and behavioral
studies, convincingly shows that the visual pathways in Spalax
have almost fully regressed and do not retain any detectable
function (1, 3–5, 7). Ocular regression to a subcutaneously
embedded atrophic eye and degeneration of the visual system is
a logical consequence of adaptation to a subterranean environ-
ment where visual cues are reduced. However, negative selec-
tion upon the neuronal components of the visual system was
accompanied by positive selection pressures resulting in main-
tenance of retinal morphology and expansion of bilateral pro-
jections to the suprachiasmatic nucleus. This pathway is re-
sponsible for mediating circadian photoentrainment (1, 4, 5),
and, similar to sighted mammals, removal of the eyes com-
pletely abolishes photoentrainment in Spalax.
In sighted mammals the photoreceptors that mediate photo-
regulation of the circadian system still remain uncharacter-
ized. Data obtained from mouse models like rd/rd and rdta/rdta
(25–27) suggest that neither rods nor cones are directly re-
quired for photoentrainment but that the mouse retina con-
tains a novel type of circadian photoreceptor(s), not located in
the photoreceptor layer. However, the circadian system in
sighted animals is not very photosensitive (28, 29) and may not
function properly in combination with a subterranean lifestyle.
Hence, the crucial question in our opinion is as follows: did
Spalax maintain a photoreceptor cell layer and functional vis-
ual photopigments basically to preserve circadian photorecep-
tion? In fact, in blind animals like Spalax, maintenance of
visual photoreceptors without any physiological importance
would go with high metabolic costs and appear to contradict
evolutionary laws (1).
Considering such admittedly circumstantial evidence we
propose that Spalax, in its adaptation to a blind subterranean
life, has rewired its retinal circuitry to maintain circadian
photoentrainment under conditions where light cues are sparse
and of low intensity. In this view, extensive deprivation of light
because of a subterranean ecotope and the subcutaneous loca-
tion of the eyes have expanded mosaic reorganization in Spalax
to complement its “traditional” non-visual photoreceptor circa-
dian system with the much more abundant and much more
sensitive visual photoreceptor system, which could be diverted
from its original function. This demanded that the full integrity
of the retinal morphology be maintained but without the need
for an optical focusing system (cornea and lens). Direct evi-
dence for this hypothesis unfortunately is very hard to provide.
The Spalax underground ecotope cannot very well be mim-
icked, and animals do not breed in captivity. Hence, recombi-
nant DNA technology that could lead to identification of circa-
dian pigment(s) (e.g. mutagenic screens and gene targeting) is
not currently available for Spalax. Determination of suffi-
ciently accurate action spectra for the circadian photoresponses
in Spalax to provide unequivocal evidence for the involvement
of visual pigments is also not a feasible task (6).
However, another circumstantial argument can be put for-
ward. The degenerate eye of Spalax shares several character-
istics with the pineal organ of non-mammalian vertebrates.
Both lack a focusing lens, are located subcutaneously, and
exhibit a much lower degree of organization of the outer seg-
ments of the photoreceptor cells than observed for visual pho-
FIG. 5. Spectral absorbance data from four Spalax photore-
ceptor outer segments obtained by microspectrophotometry.
Open squares were measured before illumination, and solid squares
were measured after 3 min of illumination with white light. The dashed
curve represents a visual template (14) with a lmax of 497 nm. This
yields a reasonable fit, but better fits are exhibited by 500- to 505-nm
templates. The 505-nm template is represented by the solid curve.
FIG. 6. Rhodopsin and Gta localization in Spalax and mouse
retina. A and B display the retina morphology of Spalax and C57BL6
mouse using a hematoxylin/eosin staining. C–F display immunohisto-
logical analysis of Spalax and mouse retina incubated with the mono-
clonal anti-rhodopsin antibody 1D4 (C and D) and with the polyclonal
anti-Gt antibody CERN9412 (E and F), respectively. Results identical to
C and D were obtained with the polyclonal anti-rhodopsin antibody
CERN886 and to E and F with a monoclonal anti-Gta antibody. RPE,
retina pigment epithelium; OS, outer segments; IS, inner segments;
ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nu-
clear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Bar
represents 60 mm for all panels.























toreceptors (28, 30–32). The pineal photoreceptors also contain
rod-like, as well as cone-like, photopigments (31, 33) and have
unequivocally been shown to function as photodetectors medi-
ating photoperiodic information in non-mammalian verte-
brates (28, 32, 34, 35).
Conclusion—We present the first extensive characterization
of a visual pigment cloned from a blind animal, the mole rat
Spalax ehrenbergi. In view of its high homology to rod pigments
of sighted animals and the functional properties of the corre-
sponding recombinant protein, this pigment represents the rod
visual pigment of Spalax. We provide evidence that the rod
photoreceptor cell of Spalax, despite the strongly regressed
state of the eye, still contains the primary elements required
for a role as a functional photoreceptor. In view of the striking
evolutionary conservation and the in vitro and in vivo function-
ality of the Spalax rod visual pigment we propose that during
evolutionary adaptation to a predominantly subterranean life-
style the visual photoreceptor system in this blind mammal has
been reprogrammed to play a major role in photoperiodic en-
trainment. Extrapolating this to sighted animals, one could
argue that this might imply some yet unidentified role, e.g.
developmental or regulatory, of the visual system in circadian
photoentrainment in general. This might explain, for instance,
why early ablation of photoreceptors during retinal develop-
ment changes the photosensitivity of the circadian system (25).
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